Document Detail


Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS.
MedLine Citation:
PMID:  18333287     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This case report describes an exacerbation of AIDS-associated Kaposi sarcoma (KS) in the setting of iatrogenic Cushing syndrome caused by an interaction between ritonavir-boosted atazanavir and fluticasone. Discontinuation of fluticasone resulted in resolution of the cutaneous KS. Clinicians should be aware of this potential drug-drug interaction that can result in increased corticosteroid levels. Inhaled corticosteroids should be used cautiously in persons with HIV/AIDS who have a history of KS and are being treated with a boosted atazanavir regimen because this can potentially exacerbate KS.
Authors:
Sadao Jinno; Cyril Goshima
Related Documents :
16882707 - Epstein-barr virus nuclear antigen 2 inhibits aid expression during ebv-driven b-cell g...
6147547 - Clinical findings and serological evidence of htlv-iii infection in homosexual contacts...
19625587 - Increasing incidence of kaposi's sarcoma in black south africans in kwazulu-natal, sout...
6357687 - Acquired immune deficiency syndrome and the management of associated opportunistic infe...
2764037 - Genetic aspects of artificial insemination with donor semen: the french cecos federatio...
21622367 - Fossil ericaceae from new zealand: deconstructing the use of fossil evidence in histori...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The AIDS reader     Volume:  18     ISSN:  1053-0894     ISO Abbreviation:  AIDS Read     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-22     Completed Date:  2008-03-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9206753     Medline TA:  AIDS Read     Country:  United States    
Other Details:
Languages:  eng     Pagination:  100-4     Citation Subset:  IM; X    
Affiliation:
Department of Medicine, University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Androstadienes / adverse effects*
Anti-Inflammatory Agents / adverse effects*
Cushing Syndrome* / complications,  drug therapy
Drug Interactions
HIV Infections* / complications,  drug therapy
HIV Protease Inhibitors / adverse effects*
Humans
Iatrogenic Disease
Male
Middle Aged
Oligopeptides / adverse effects
Pyridines / adverse effects
Ritonavir / adverse effects
Sarcoma, Kaposi / physiopathology*
Chemical
Reg. No./Substance:
0/Androstadienes; 0/Anti-Inflammatory Agents; 0/HIV Protease Inhibitors; 0/Oligopeptides; 0/Pyridines; 0/Ritonavir; 198904-31-3/atazanavir; 90566-53-3/fluticasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glial cell development and function in the Drosophila visual system.
Next Document:  The Wip1 phosphatase and Mdm2: cracking the "Wip" on p53 stability.